Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy

New remission criteria for RA: 'modern times' in rheumatology--not a silent film, rather a 3D movie

(2011) L. T. H. Jacobsson et al.   ANNALS OF THE RHEUMATIC DISEASES

Obesity and Inflammation – Targets for OA Therapy

(2010) F. Iannone et al.   CURRENT DRUG TARGETS

Correlation between BMI and PASI in patients affected by moderate to severe psoriasis undergoing biological therapy

(2010) F. Bardazzi et al.   Dermatologic Therapy

Obesity and psoriasis: From the Medical Board of the National Psoriasis Foundation

(2010) Samuel Bremmer et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register

(2010) A. A. Saad et al.   RHEUMATOLOGY

DAS-28-based EULAR response and HAQ improvement in rheumatoid arthritis patients switching between TNF antagonists

(2009) Federico Navarro-Sarabia et al.   BMC MUSCULOSKELETAL DISORDERS

Relationship of psoriasis severity to obesity using same-gender siblings as controls for obesity

(2008) M. L. Murray et al.   CLINICAL AND EXPERIMENTAL DERMATOLOGY